{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:30:20Z","timestamp":1790796620266,"version":"4.1.0"},"reference-count":25,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2010.0075","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:19:15Z","timestamp":1525238355000},"source":"Crossref","is-referenced-by-count":100,"title":["Diabetic Retinopathy"],"prefix":"10.3238","author":[{"given":"Aris N.","family":"Kollias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Ulbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2010,2,5]]},"reference":[{"key":"10.3238\/arztebl.2010.0075_ref1","doi-asserted-by":"crossref","unstructured":"H\u00f6rle S, Gr\u00fcner F, Kroll P: Epidemiologie diabetischer Erblindungen \u2013 eine \u00dcbersicht. Klin Monatsbl Augenheilkd 2002; 219(11): 777\u201384","DOI":"10.1055\/s-2002-36318"},{"key":"10.3238\/arztebl.2010.0075_ref2","unstructured":"Hamilton AMP, Ulbig MW, Polkinghome P: Management of diabetic retinopathy. London, BMJ Publishing Group, 1996."},{"key":"10.3238\/arztebl.2010.0075_ref3","doi-asserted-by":"crossref","unstructured":"Jonas JB: Intravitreal Triamcinolone acetonide for diabetic retinopathy . Dev Ophthalmol 2007; 39: 96\u2013110","DOI":"10.1159\/000098502"},{"key":"10.3238\/arztebl.2010.0075_ref4","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group . Early treatment diabetic retinopathy study. Ophthalmology 1991; Suppl 5, 98: 739\u2013840.","DOI":"10.1016\/S0161-6420(13)38009-9"},{"key":"10.3238\/arztebl.2010.0075_ref5","doi-asserted-by":"crossref","unstructured":"Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW: Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2009; 373: 1364\u201371","DOI":"10.1016\/S0140-6736(09)60218-X"},{"key":"10.3238\/arztebl.2010.0075_ref6","doi-asserted-by":"crossref","unstructured":"Blum M, Kloos C, Muller N, et al.: Pr\u00e4valenz der diabetischen Retinopathie. Studie bei Versicherten der Deutschen Betriebskrankenkasse 2002\u20132004. Ophthalmologe 2007; 104(6): 499\u2013504","DOI":"10.1007\/s00347-007-1522-0"},{"key":"10.3238\/arztebl.2010.0075_ref7","unstructured":"Ulbig MW, Kampik A, Hamilton AM: Diabetische Retinopathie. Epidemiologie, Risikofaktoren und Stadieneinteilung. Ophthalmologe 1993; 90(2): 197\u2013209"},{"key":"10.3238\/arztebl.2010.0075_ref8","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin dependent diabetes mellitus. New Engl J Med 1993; 329: 977\u2013986","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.3238\/arztebl.2010.0075_ref9","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352(9131): 837\u201353","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.3238\/arztebl.2010.0075_ref10","doi-asserted-by":"crossref","unstructured":"Schmieder R E; Martin S; Lang G E; Bramlage P; B\u00f6hm M: Angiotensin blockade to reduce microvascular damage in diabetes mellitus [Angiotensinblockade zur Reduktion mikrovaskul\u00e4rer Sch\u00e4den bei Diabetes]. Dtsch Arztebl Int 2009; 106(34\u201335): 556\u201362","DOI":"10.3238\/arztebl.2009.0556"},{"key":"10.3238\/arztebl.2010.0075_ref11","doi-asserted-by":"crossref","unstructured":"Rosenstock J, Fonseca V, McGill JB et al.: Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomized, open-label study. Diabetologia 13\u20136\u20132009; [EPUB ahead of press","DOI":"10.1007\/s00125-009-1415-7"},{"key":"10.3238\/arztebl.2010.0075_ref12","doi-asserted-by":"crossref","unstructured":"Chaturvedi N, Sjolie AK, Stephenson JM, et al.: Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998; 351 (9095): 28\u201331","DOI":"10.1016\/S0140-6736(97)06209-0"},{"key":"10.3238\/arztebl.2010.0075_ref13","doi-asserted-by":"crossref","unstructured":"UKPDS 39. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; (317): 713\u201320","DOI":"10.1136\/bmj.317.7160.713"},{"key":"10.3238\/arztebl.2010.0075_ref14","doi-asserted-by":"crossref","unstructured":"Chaturvedi N, Porta M, Klein R, et al.: Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled -trials. Lancet 2008; 372: 1394\u2013402","DOI":"10.1016\/S0140-6736(08)61412-9"},{"key":"10.3238\/arztebl.2010.0075_ref15","doi-asserted-by":"crossref","unstructured":"Sjolie AK, Klein R, Porta M, et al.: Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 2008; 372 (9647): 1385\u201393","DOI":"10.1016\/S0140-6736(08)61411-7"},{"key":"10.3238\/arztebl.2010.0075_ref16","doi-asserted-by":"crossref","unstructured":"Keech AC, Mitchell P, Summanen PA, et al.: Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370(9600): 1687\u201397","DOI":"10.1016\/S0140-6736(07)61607-9"},{"key":"10.3238\/arztebl.2010.0075_ref17","doi-asserted-by":"crossref","unstructured":"Lanzagorta-Aresti A, Palacios-Pozo E, Menezo Rozalen JL, Navea-Tejerina A: Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study. Retina 2009; 29(4): 530\u20135","DOI":"10.1097\/IAE.0b013e31819c6302"},{"key":"10.3238\/arztebl.2010.0075_ref18","doi-asserted-by":"crossref","unstructured":"The Diabetic Retinopathy Study Research Group: Preliminary report on the effects of photocoagulation therapy. Am J Ophthalmol 1976; 81: 383\u201396","DOI":"10.1016\/0002-9394(76)90292-0"},{"key":"10.3238\/arztebl.2010.0075_ref19","doi-asserted-by":"crossref","unstructured":"Gandorfer A, Kampik A: Pars-plana-Vitrektomie bei diabetischer Retinopathie. Vom pathogenetischen Prinzip zur operativen Strategie. Ophthalmologe 2000; 97(5): 325\u201330","DOI":"10.1007\/s003470050531"},{"key":"10.3238\/arztebl.2010.0075_ref20","doi-asserted-by":"crossref","unstructured":"The Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial. Diabetic Retinopathy Vitrectomy Study Report 4. Ophthalmology 1988; 95(10): 1321\u201334","DOI":"10.1016\/S0161-6420(88)33014-9"},{"key":"10.3238\/arztebl.2010.0075_ref21","doi-asserted-by":"crossref","unstructured":"Beck RW, Edwards AR, Aiello LP, et al.: Three-year follow-up of a randomized trial comparing focal\/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009; 127(3): 245\u201351","DOI":"10.1001\/archophthalmol.2008.610"},{"key":"10.3238\/arztebl.2010.0075_ref22","doi-asserted-by":"crossref","unstructured":"Cunnigham ET, Adamis AP, Altaweel M, et al.; Macugen Diabetic Retinopathy Study Group: A phase II randomized double-masked trial of pegaptanib, anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005; 112(10): 1747\u201357","DOI":"10.1016\/j.ophtha.2005.06.007"},{"key":"10.3238\/arztebl.2010.0075_ref23","doi-asserted-by":"crossref","unstructured":"Do DV, Nguyen QD, Shah SM, et al.: An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. Br J Ophthalmol 2009; 93(2): 144\u20139","DOI":"10.1136\/bjo.2008.138271"},{"key":"10.3238\/arztebl.2010.0075_ref24","doi-asserted-by":"crossref","unstructured":"Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol 2007; 125(3): 318\u201324","DOI":"10.1001\/archopht.125.3.318"},{"key":"10.3238\/arztebl.2010.0075_ref25","doi-asserted-by":"crossref","unstructured":"Campochiaro PA: Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci 2004; 45(3): 922\u201331","DOI":"10.1167\/iovs.03-0955"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T21:43:14Z","timestamp":1751578994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,5]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2010.0075","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/s00417-017-3638-5","asserted-by":"object"},{"id-type":"doi","id":"10.1155\/2016\/4345936","asserted-by":"object"},{"id-type":"doi","id":"10.15171\/jnp.2016.26","asserted-by":"object"},{"id-type":"doi","id":"10.1155\/2016\/8405395","asserted-by":"object"},{"id-type":"doi","id":"10.1155\/2015\/864871","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,5]]}}}